Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Megestrol Acetate × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 3 Other 1

Conditions

Overweight 1 Obesity 1 Infertility 1 Endometrial Neoplasms 1

Interventions

tegaserod 1 semaglutide 1 penclomedine 1 aluminum hydroxide, magnesium hydroxide, drug combination 1 Thioctic Acid 1 Tablets 1 Radiation 1 Metformin 1 Megestrol Acetate 1 Low-Level Light Therapy 1 Lidocaine 1 Exercise 1 Exenatide 1 Diphenhydramine 1 Buspirone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05316467 2025-08-11

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

Fudan University

Phase 2/3 Recruiting

GynecologicOther

Infertility, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon ⚡